FHIR Cross-Version Extensions package for FHIR R4 from FHIR R5
0.0.1-snapshot-2 - informative International flag

FHIR Cross-Version Extensions package for FHIR R4 from FHIR R5 - Version 0.0.1-snapshot-2. See the Directory of published versions

ValueSet: Cross-version VS for R5.VaccineAdministeredValueSet for use in FHIR R4

Official URL: http://hl7.org/fhir/5.0/ValueSet/R5-vaccine-code-for-R4 Version: 0.0.1-snapshot-2
Standards status: Informative Maturity Level: 1 Responsible: Public Health Computable Name: R5_vaccine_code_for_R4

This cross-version ValueSet represents concepts from http://hl7.org/fhir/ValueSet/vaccine-code 5.0.0 for use in FHIR R4. Concepts not present here have direct equivalent mappings crossing all versions from R5 to R4.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

This value set includes codes based on the following rules:

 

Expansion

Expansion from tx.fhir.org based on codesystem Vaccine Administered Code Set (CVX) version20250715

This value set contains 360 concepts

CodeSystemDisplay
  01http://hl7.org/fhir/sid/cvxDTP
  02http://hl7.org/fhir/sid/cvxOPV, trivalent
  03http://hl7.org/fhir/sid/cvxMMR
  04http://hl7.org/fhir/sid/cvxM/R
  05http://hl7.org/fhir/sid/cvxmeasles
  06http://hl7.org/fhir/sid/cvxrubella
  07http://hl7.org/fhir/sid/cvxmumps
  08http://hl7.org/fhir/sid/cvxHep B, adolescent or pediatric
  09http://hl7.org/fhir/sid/cvxTd (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
  10http://hl7.org/fhir/sid/cvxIPV
  11http://hl7.org/fhir/sid/cvxpertussis
  12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin
  13http://hl7.org/fhir/sid/cvxTIG
  14http://hl7.org/fhir/sid/cvxIG, unspecified formulation
  15http://hl7.org/fhir/sid/cvxinfluenza, split (incl. purified surface antigen)
  16http://hl7.org/fhir/sid/cvxinfluenza, whole
  17http://hl7.org/fhir/sid/cvxHib, unspecified formulation
  18http://hl7.org/fhir/sid/cvxrabies, intramuscular injection
  19http://hl7.org/fhir/sid/cvxBCG
  20http://hl7.org/fhir/sid/cvxDTaP
  21http://hl7.org/fhir/sid/cvxvaricella
  22http://hl7.org/fhir/sid/cvxDTP-Hib
  23http://hl7.org/fhir/sid/cvxplague
  24http://hl7.org/fhir/sid/cvxAnthrax, pre-exposure prophylaxis, post-exposure prophylaxis
  25http://hl7.org/fhir/sid/cvxtyphoid, oral
  26http://hl7.org/fhir/sid/cvxcholera, unspecified formulation
  27http://hl7.org/fhir/sid/cvxbotulinum antitoxin
  28http://hl7.org/fhir/sid/cvxDT (pediatric)
  29http://hl7.org/fhir/sid/cvxCMVIG
  30http://hl7.org/fhir/sid/cvxHBIG
  31http://hl7.org/fhir/sid/cvxHep A, pediatric, unspecified formulation
  32http://hl7.org/fhir/sid/cvxmeningococcal MPSV4
  33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide PPV23
  34http://hl7.org/fhir/sid/cvxRIG
  35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed
  36http://hl7.org/fhir/sid/cvxVZIG
  37http://hl7.org/fhir/sid/cvxyellow fever live
  38http://hl7.org/fhir/sid/cvxrubella/mumps
  39http://hl7.org/fhir/sid/cvxJapanese encephalitis SC
  40http://hl7.org/fhir/sid/cvxrabies, intradermal injection
  41http://hl7.org/fhir/sid/cvxtyphoid, parenteral
  42http://hl7.org/fhir/sid/cvxHep B, adolescent/high risk infant
  43http://hl7.org/fhir/sid/cvxHep B, adult
  44http://hl7.org/fhir/sid/cvxHep B, high-dosage, dialysis or IC
  45http://hl7.org/fhir/sid/cvxHep B, unspecified formulation
  46http://hl7.org/fhir/sid/cvxHib (PRP-D)
  47http://hl7.org/fhir/sid/cvxHib (HbOC)
  48http://hl7.org/fhir/sid/cvxHib (PRP-T)
  49http://hl7.org/fhir/sid/cvxHib (PRP-OMP)
  50http://hl7.org/fhir/sid/cvxDTaP-Hib
  51http://hl7.org/fhir/sid/cvxHib-Hep B
  52http://hl7.org/fhir/sid/cvxHep A, adult
  53http://hl7.org/fhir/sid/cvxtyphoid, parenteral, AKD (U.S. military)
  54http://hl7.org/fhir/sid/cvxadenovirus, type 4
  55http://hl7.org/fhir/sid/cvxadenovirus, type 7
  56http://hl7.org/fhir/sid/cvxdengue fever tetravalent
  57http://hl7.org/fhir/sid/cvxhantavirus
  58http://hl7.org/fhir/sid/cvxHep C
  59http://hl7.org/fhir/sid/cvxHep E
  60http://hl7.org/fhir/sid/cvxherpes simplex 2
  61http://hl7.org/fhir/sid/cvxHIV
  62http://hl7.org/fhir/sid/cvxHPV, quadrivalent
  63http://hl7.org/fhir/sid/cvxJunin virus
  64http://hl7.org/fhir/sid/cvxleishmaniasis
  65http://hl7.org/fhir/sid/cvxleprosy
  66http://hl7.org/fhir/sid/cvxLyme disease
  67http://hl7.org/fhir/sid/cvxmalaria
  68http://hl7.org/fhir/sid/cvxmelanoma
  69http://hl7.org/fhir/sid/cvxparainfluenza-3
  70http://hl7.org/fhir/sid/cvxQ fever
  71http://hl7.org/fhir/sid/cvxRSV-IGIV
  72http://hl7.org/fhir/sid/cvxrheumatic fever
  73http://hl7.org/fhir/sid/cvxRift Valley fever
  74http://hl7.org/fhir/sid/cvxrotavirus, tetravalent
  75http://hl7.org/fhir/sid/cvxVaccinia (smallpox, mpox), live
  76http://hl7.org/fhir/sid/cvxStaphylococcus bacterio lysate
  77http://hl7.org/fhir/sid/cvxTick-borne encephalitis vaccine (non-US)
  78http://hl7.org/fhir/sid/cvxtularemia vaccine
  79http://hl7.org/fhir/sid/cvxvaccinia immune globulin
  80http://hl7.org/fhir/sid/cvxVEE, live
  81http://hl7.org/fhir/sid/cvxVEE, inactivated
  82http://hl7.org/fhir/sid/cvxadenovirus, unspecified formulation
  83http://hl7.org/fhir/sid/cvxHep A, ped/adol, 2 dose
  84http://hl7.org/fhir/sid/cvxHep A, ped/adol, 3 dose
  85http://hl7.org/fhir/sid/cvxHep A, unspecified formulation
  86http://hl7.org/fhir/sid/cvxIG
  87http://hl7.org/fhir/sid/cvxIGIV
  88http://hl7.org/fhir/sid/cvxinfluenza, unspecified formulation
  89http://hl7.org/fhir/sid/cvxpolio, unspecified formulation
  90http://hl7.org/fhir/sid/cvxrabies, unspecified formulation
  91http://hl7.org/fhir/sid/cvxtyphoid, unspecified formulation
  92http://hl7.org/fhir/sid/cvxVEE, unspecified formulation
  93http://hl7.org/fhir/sid/cvxRSV-MAb
  94http://hl7.org/fhir/sid/cvxMMRV
  95http://hl7.org/fhir/sid/cvxTST-OT tine test
  96http://hl7.org/fhir/sid/cvxTST-PPD intradermal
  97http://hl7.org/fhir/sid/cvxTST-PPD tine test
  98http://hl7.org/fhir/sid/cvxTST, unspecified formulation
  99http://hl7.org/fhir/sid/cvxRESERVED - do not use
  100http://hl7.org/fhir/sid/cvxpneumococcal conjugate PCV 7
  101http://hl7.org/fhir/sid/cvxtyphoid, ViCPs
  102http://hl7.org/fhir/sid/cvxDTP-Hib-Hep B
  103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate
  104http://hl7.org/fhir/sid/cvxHep A-Hep B
  105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) diluted
  106http://hl7.org/fhir/sid/cvxDTaP, 5 pertussis antigens
  107http://hl7.org/fhir/sid/cvxDTaP, unspecified formulation
  108http://hl7.org/fhir/sid/cvxmeningococcal ACWY, unspecified formulation
  109http://hl7.org/fhir/sid/cvxpneumococcal, unspecified formulation
  110http://hl7.org/fhir/sid/cvxDTaP-Hep B-IPV
  111http://hl7.org/fhir/sid/cvxInfluenza, live, trivalent, intranasal, PF
  112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation
  113http://hl7.org/fhir/sid/cvxTd (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
  114http://hl7.org/fhir/sid/cvxmeningococcal MCV4P
  115http://hl7.org/fhir/sid/cvxTdap
  116http://hl7.org/fhir/sid/cvxrotavirus, pentavalent
  117http://hl7.org/fhir/sid/cvxVZIG (IND)
  118http://hl7.org/fhir/sid/cvxHPV, bivalent
  119http://hl7.org/fhir/sid/cvxrotavirus, monovalent
  120http://hl7.org/fhir/sid/cvxDTaP-Hib-IPV
  121http://hl7.org/fhir/sid/cvxzoster live
  122http://hl7.org/fhir/sid/cvxrotavirus, unspecified formulation
  123http://hl7.org/fhir/sid/cvxinfluenza, H5N1-1203
  125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, nasal
  126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free
  127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09
  128http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, all formulations
  129http://hl7.org/fhir/sid/cvxJapanese Encephalitis, unspecified formulation
  130http://hl7.org/fhir/sid/cvxDTaP-IPV
  131http://hl7.org/fhir/sid/cvxtyphus, historical
  132http://hl7.org/fhir/sid/cvxDTaP-IPV-HIB-HEP B, historical
  133http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV 13
  134http://hl7.org/fhir/sid/cvxJapanese Encephalitis IM
  135http://hl7.org/fhir/sid/cvxInfluenza, high-dose, trivalent, PF
  136http://hl7.org/fhir/sid/cvxMeningococcal MCV4O
  137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation
  138http://hl7.org/fhir/sid/cvxTd (adult)
  139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation
  140http://hl7.org/fhir/sid/cvxInfluenza, split virus, trivalent, PF
  141http://hl7.org/fhir/sid/cvxInfluenza, split virus, trivalent, preservative
  142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed
  143http://hl7.org/fhir/sid/cvxAdenovirus types 4 and 7
  144http://hl7.org/fhir/sid/cvxinfluenza, seasonal, intradermal, preservative free
  145http://hl7.org/fhir/sid/cvxRSV-MAb (new)
  146http://hl7.org/fhir/sid/cvxDTaP,IPV,Hib,HepB
  147http://hl7.org/fhir/sid/cvxmeningococcal MCV4, unspecified formulation
  148http://hl7.org/fhir/sid/cvxMeningococcal C/Y-HIB PRP
  149http://hl7.org/fhir/sid/cvxInfluenza, live, quadrivalent, intranasal
  150http://hl7.org/fhir/sid/cvxInfluenza, split virus, quadrivalent, PF
  151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation
  152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation
  153http://hl7.org/fhir/sid/cvxInfluenza, MDCK, trivalent, PF
  154http://hl7.org/fhir/sid/cvxHep A, IG
  155http://hl7.org/fhir/sid/cvxInfluenza, recombinant, trivalent, PF
  156http://hl7.org/fhir/sid/cvxRho(D)-IG
  157http://hl7.org/fhir/sid/cvxRho(D) -IG IM
  158http://hl7.org/fhir/sid/cvxInfluenza, split virus, quadrivalent, preservative
  159http://hl7.org/fhir/sid/cvxRho(D) - Unspecified formulation
  160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), ADJUVANTED-2013
  161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric
  162http://hl7.org/fhir/sid/cvxmeningococcal B, recombinant
  163http://hl7.org/fhir/sid/cvxmeningococcal B, OMV
  164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified
  165http://hl7.org/fhir/sid/cvxHPV9
  166http://hl7.org/fhir/sid/cvxinfluenza, intradermal, quadrivalent, preservative free
  167http://hl7.org/fhir/sid/cvxmeningococcal, unknown serogroups
  168http://hl7.org/fhir/sid/cvxInfluenza, adjuvanted, trivalent, PF
  169http://hl7.org/fhir/sid/cvxHep A, live attenuated
  170http://hl7.org/fhir/sid/cvxDTAP/IPV/HIB - non-US
  171http://hl7.org/fhir/sid/cvxInfluenza, MDCK, quadrivalent, PF
  172http://hl7.org/fhir/sid/cvxcholera, WC-rBS
  173http://hl7.org/fhir/sid/cvxcholera, BivWC
  174http://hl7.org/fhir/sid/cvxcholera, live attenuated
  175http://hl7.org/fhir/sid/cvxRabies - IM Diploid cell culture
  176http://hl7.org/fhir/sid/cvxRabies - IM fibroblast culture
  177http://hl7.org/fhir/sid/cvxPCV10
  178http://hl7.org/fhir/sid/cvxOPV bivalent
  179http://hl7.org/fhir/sid/cvxOPV ,monovalent, unspecified
  180http://hl7.org/fhir/sid/cvxtetanus immune globulin
  181http://hl7.org/fhir/sid/cvxanthrax immune globulin
  182http://hl7.org/fhir/sid/cvxOPV, Unspecified
  183http://hl7.org/fhir/sid/cvxYellow fever vaccine live - alt
  184http://hl7.org/fhir/sid/cvxYellow fever, unspecified
  185http://hl7.org/fhir/sid/cvxInfluenza, recombinant, quadrivalent, PF
  186http://hl7.org/fhir/sid/cvxInfluenza, MDCK, quadrivalent, preservative
  187http://hl7.org/fhir/sid/cvxzoster recombinant
  188http://hl7.org/fhir/sid/cvxzoster, unspecified formulation
  189http://hl7.org/fhir/sid/cvxHepB-CpG
  190http://hl7.org/fhir/sid/cvxTyphoid conjugate vaccine (TCV)
  191http://hl7.org/fhir/sid/cvxmeningococcal A polysaccharide (non-US)
  192http://hl7.org/fhir/sid/cvxmeningococcal AC polysaccharide (non-US)
  193http://hl7.org/fhir/sid/cvxHep A-Hep B, pediatric/adolescent
  194http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere
  195http://hl7.org/fhir/sid/cvxDT, IPV adsorbed
  196http://hl7.org/fhir/sid/cvxTd, adsorbed, preservative free, adult use, Lf unspecified
  197http://hl7.org/fhir/sid/cvxInfluenza, high-dose, quadrivalent, PF
  198http://hl7.org/fhir/sid/cvxDTP-hepB-Hib Pentavalent Non-US
  200http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, pediatric, preservative free
  201http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere, quadrivalent, PF
  202http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, quadrivalent, with preservative
  203http://hl7.org/fhir/sid/cvxmeningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
  204http://hl7.org/fhir/sid/cvxEbola Zaire vaccine, live, recombinant, 1mL dose
  205http://hl7.org/fhir/sid/cvxInfluenza, adjuvanted, quadrivalent, PF
  206http://hl7.org/fhir/sid/cvxVaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
  207http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
  208http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
  210http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
  211http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
  212http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
  213http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
  214http://hl7.org/fhir/sid/cvxEbola, unspecified
  215http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
  216http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
  217http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
  218http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
  219http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
  220http://hl7.org/fhir/sid/cvxHepB recombinant, 3-antigen, Al(OH)3
  221http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
  222http://hl7.org/fhir/sid/cvxTick-borne encephalitis, unspecified
  223http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.25mL
  224http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.5mL
  225http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
  226http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
  227http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
  228http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
  229http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
  230http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
  231http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, high-dose, quadrivalent
  300http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
  301http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
  302http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose
  303http://hl7.org/fhir/sid/cvxRSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
  304http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV), unspecified
  305http://hl7.org/fhir/sid/cvxRSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
  306http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
  307http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
  308http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
  309http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
  310http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
  311http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
  312http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
  313http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
  314http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) vaccine, unspecified
  315http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) MAB, unspecified
  316http://hl7.org/fhir/sid/cvxMeningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
  317http://hl7.org/fhir/sid/cvxChikungunya live attenuated vaccine, 0.5 mL, PF
  318http://hl7.org/fhir/sid/cvxAnthrax, post-exposure prophylaxis
  319http://hl7.org/fhir/sid/cvxAnthrax vaccine, unspecified
  320http://hl7.org/fhir/sid/cvxInfluenza, MDCK, trivalent, preservative
  321http://hl7.org/fhir/sid/cvxInfluenza-avian, H5N8, monovalent, PF
  322http://hl7.org/fhir/sid/cvxInfluenza-avian, H5N8, monovalent, preservative
  323http://hl7.org/fhir/sid/cvxInfluenza-avian, H5, unspecified formulation
  324http://hl7.org/fhir/sid/cvxPoliovirus, inactivated, fractional-dose (fIPV)
  325http://hl7.org/fhir/sid/cvxVaccinia (smallpox, mpox), unspecified
  326http://hl7.org/fhir/sid/cvxRSV, mRNA, injectable, PF
  327http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
  328http://hl7.org/fhir/sid/cvxMeningococcal oligosaccharide (MenACWY), (MenB), PF
  329http://hl7.org/fhir/sid/cvxChikungunya, VLP, recombinant, 0.8 mL, PF
  330http://hl7.org/fhir/sid/cvxDengue fever, unspecified
  331http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere, trivalent, PF
  332http://hl7.org/fhir/sid/cvxRSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
  333http://hl7.org/fhir/sid/cvxInfluenza, live, trivalent, intranasal, self/caregiver admin, PF
  500http://hl7.org/fhir/sid/cvxCOVID-19 Non-US Vaccine, Product Unknown
  501http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (QAZCOVID-IN)
  502http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (COVAXIN)
  503http://hl7.org/fhir/sid/cvxCOVID-19 LAV Non-US Vaccine (COVIVAC)
  504http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik Light)
  505http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik V)
  506http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
  507http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
  508http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
  509http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (EpiVacCorona)
  510http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
  511http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
  512http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
  513http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
  514http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
  515http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
  516http://hl7.org/fhir/sid/cvxCOV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
  517http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
  518http://hl7.org/fhir/sid/cvxCOVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
  519http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
  520http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
  521http://hl7.org/fhir/sid/cvxCOVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
  801http://hl7.org/fhir/sid/cvxAS03 Adjuvant
  998http://hl7.org/fhir/sid/cvxno vaccine administered
  999http://hl7.org/fhir/sid/cvxunknown
  AGRPALurn:oid:1.2.36.1.2001.1005.17Agrippal
  AVAXMurn:oid:1.2.36.1.2001.1005.17Avaxim
  BCGurn:oid:1.2.36.1.2001.1005.17BCG
  CDTurn:oid:1.2.36.1.2001.1005.17CDT
  CMXurn:oid:1.2.36.1.2001.1005.17COMVAX
  DTPurn:oid:1.2.36.1.2001.1005.17Triple Antigen
  DTPAurn:oid:1.2.36.1.2001.1005.17DTPa
  ENGPurn:oid:1.2.36.1.2001.1005.17Engerix B
  FLRIXurn:oid:1.2.36.1.2001.1005.17Fluarix
  FLUVAXurn:oid:1.2.36.1.2001.1005.17Fluvax
  FLVRNurn:oid:1.2.36.1.2001.1005.17Fluvirin
  FVXJNRurn:oid:1.2.36.1.2001.1005.17Fluvax Junior
  GNDIPurn:oid:1.2.36.1.2001.1005.17Diphtheria
  GNFLUurn:oid:1.2.36.1.2001.1005.17Influenza
  GNHEPurn:oid:1.2.36.1.2001.1005.17Hepatitis B
  GNHIBurn:oid:1.2.36.1.2001.1005.17HIB
  GNHPAurn:oid:1.2.36.1.2001.1005.17Hepatitis A
  GNJENurn:oid:1.2.36.1.2001.1005.17Japanese Encephalitis
  GNMEAurn:oid:1.2.36.1.2001.1005.17Measles
  GNMENurn:oid:1.2.36.1.2001.1005.17Meningococcal C
  GNMUMurn:oid:1.2.36.1.2001.1005.17Mumps
  GNPNEurn:oid:1.2.36.1.2001.1005.17Pneumococcal
  GNPOLurn:oid:1.2.36.1.2001.1005.17Polio
  GNROXurn:oid:1.2.36.1.2001.1005.17Rotavirus
  GNRUBurn:oid:1.2.36.1.2001.1005.17Rubella
  GNTETurn:oid:1.2.36.1.2001.1005.17Tetanus
  GNVARurn:oid:1.2.36.1.2001.1005.17Varicella
  HATWNJurn:oid:1.2.36.1.2001.1005.17Twinrix Junior
  HAVAQurn:oid:1.2.36.1.2001.1005.17Vaqta Paed/Adol
  HAVJurn:oid:1.2.36.1.2001.1005.17Havrix Junior
  HBOCurn:oid:1.2.36.1.2001.1005.17HibTITER
  HBVurn:oid:1.2.36.1.2001.1005.17HBV
  HBVPurn:oid:1.2.36.1.2001.1005.17HBVAX II
  HBXurn:oid:1.2.36.1.2001.1005.17Hiberix
  IFHXurn:oid:1.2.36.1.2001.1005.17Infanrix Hexa
  IFIPurn:oid:1.2.36.1.2001.1005.17Infanrix-IPV
  IFPAurn:oid:1.2.36.1.2001.1005.17Infanrix Penta
  IFXurn:oid:1.2.36.1.2001.1005.17Infanrix
  IFXBurn:oid:1.2.36.1.2001.1005.17InfanrixHepB
  INFLUVurn:oid:1.2.36.1.2001.1005.17Influvac
  IPVurn:oid:1.2.36.1.2001.1005.17IPOL
  JEVAXurn:oid:1.2.36.1.2001.1005.17JE-VAX
  MENJUGurn:oid:1.2.36.1.2001.1005.17Menjugate
  MENTECurn:oid:1.2.36.1.2001.1005.17Meningitec
  MENUMEurn:oid:1.2.36.1.2001.1005.17Menomune
  MENVAXurn:oid:1.2.36.1.2001.1005.17Mencevax ACWY
  MMRurn:oid:1.2.36.1.2001.1005.17MMR
  MMRCSLurn:oid:1.2.36.1.2001.1005.17MMR II
  MMRSKBurn:oid:1.2.36.1.2001.1005.17Priorix
  MNTRXurn:oid:1.2.36.1.2001.1005.17Menitorix
  NEISVCurn:oid:1.2.36.1.2001.1005.17NeisVac-C
  OPVurn:oid:1.2.36.1.2001.1005.17Polio
  Purn:oid:1.2.36.1.2001.1005.17Pertussis
  PANVAXurn:oid:1.2.36.1.2001.1005.17Panvax
  PDCLurn:oid:1.2.36.1.2001.1005.17Pediacel
  PLCLurn:oid:1.2.36.1.2001.1005.17Poliacel
  PNEUMOurn:oid:1.2.36.1.2001.1005.17Pneumovax
  PRPDurn:oid:1.2.36.1.2001.1005.17ProHIBit
  PROQADurn:oid:1.2.36.1.2001.1005.17ProQuad
  PRPOMPurn:oid:1.2.36.1.2001.1005.17PedvaxHIB
  PRPTurn:oid:1.2.36.1.2001.1005.17ActHIB
  PRVNRurn:oid:1.2.36.1.2001.1005.17Prevenar 7
  PRVTHurn:oid:1.2.36.1.2001.1005.17Prevenar 13
  PRXTEXurn:oid:1.2.36.1.2001.1005.17Priorix-Tetra
  QDCLurn:oid:1.2.36.1.2001.1005.17Quadracel
  ROTRIXurn:oid:1.2.36.1.2001.1005.17Rotarix
  ROTTEQurn:oid:1.2.36.1.2001.1005.17Rotateq
  SYNFLXurn:oid:1.2.36.1.2001.1005.17Synflorix
  TCLurn:oid:1.2.36.1.2001.1005.17Tripacel
  VAXGRPurn:oid:1.2.36.1.2001.1005.17Vaxigrip
  VGRJNRurn:oid:1.2.36.1.2001.1005.17Vaxigrip Junior
  VLRIXurn:oid:1.2.36.1.2001.1005.17Varilrix
  VRVAXurn:oid:1.2.36.1.2001.1005.17Varivax

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code